new ACE inhibitor, Mavik (trandolapril) by Abbott
April 2003
You'll see a new ACE inhibitor, Mavik (trandolapril) by Abbott.
It's the tenth ACE inhibitor to hit the market.
It's approved for hypertension...and for increasing survival in patients who just had a heart attack.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote